To date, no prospective data involving patients with migraine treated with anti‐CGRP mAbs and other mAbs for comorbid diseases are available, except for a small case series of patients with multiple sclerosis (MS) treated with mAbs [7]. The gene discussed is CALCA; the disease is multiple sclerosis.